Ashley A. Stegelmeier

427 citations
16 papers · 283 indexed · h-index 11
Topics
Virus-based gene therapy research (7 papers)CAR-T cell therapy research (4 papers)Immune cells in cancer (3 papers)
Partner nations
CanadaUnited StatesIran

In The Last Decade

Ashley A. Stegelmeier

16 papers receiving 282 citations

Peers

Ashley A. Stegelmeier
Comparison fields: 5 of 75
  • Immunology 97
  • Molecular Biology 73
  • Genetics 60
  • Oncology 56
  • Plant Science 46
Replace Peng Qi with:
Peng Qi China
Pujarini Dash India
Xinyi Li China
Yukiko Abe Japan
Danielle C. Humphris Australia
Dhaneshwar Kumar United States
Shuai Gao China
Paola Smaldini Argentina
Kelly Hallstrom United States
Ashley A. Stegelmeier relative to Peng Qi China Peng Qi's profile →
Citations per field
00.5×1.5×
Peng Qi · 1×
Citations per year

Countries citing papers authored by Ashley A. Stegelmeier

Since Specialization
Citations

This map shows the geographic impact of Ashley A. Stegelmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley A. Stegelmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley A. Stegelmeier more than expected).

Fields of papers citing papers by Ashley A. Stegelmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley A. Stegelmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley A. Stegelmeier. The network helps show where Ashley A. Stegelmeier may publish in the future.

Co-authorship network of co-authors of Ashley A. Stegelmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley A. Stegelmeier. A scholar is included among the top collaborators of Ashley A. Stegelmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley A. Stegelmeier. Ashley A. Stegelmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 2
3 12
4 6
5 47
6 23
7 2
8 10
9 24
10 24
11 3
12 22
13 10
14 13
15 10
16 73

About Ashley A. Stegelmeier

Ashley A. Stegelmeier is a scholar working on Genetics, Immunology and Oncology, having authored 16 papers that have together received 283 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (4 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Immunology (97 citations), Biotechnology (21 citations) and Genetics (60 citations). Ashley A. Stegelmeier has collaborated with scholars based in Canada, United States and Iran. Frequent co-authors include Byram W. Bridle, Sarah K. Wootton, Khalil Karimi, Bernard R. Glick, Jacob P. van Vloten, Jim Petrik, Kathy Matuszewska, Lisa A. Santry, Josh D. Neufeld and Lily Chan. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Cytokine & Growth Factor Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026